Guide

Plan reviews: cadence by payer and the update that counts

Summary

No single law sets a universal deadline for updating a treatment plan; the interval is set by your own clinical judgment, your payer's authorization period, or an accrediting body's standard, commonly every 90 days as a practice convention, always at reauthorization, and immediately if the client's clinical picture changes meaningfully. Check your specific payer's authorization letter for the actual date that controls, and treat the review as a genuine update, not a re-signed copy of the same plan.

By Gale Editorial · Updated 2026-07-26. Every figure cited to a dated source. How we write.

There's no universal deadline — the driver is your payer or your own judgment

No single federal law sets a universal number of days between treatment-plan updates; the actual deadline you are working against is whichever is most specific to your situation, a payer's authorization period, an accrediting body's standard, or your own clinical judgment about when the plan stops reflecting the client's actual treatment. Treat 'how often' as a question with a different answer for every payer relationship, not one fixed number.

This is unusual among documentation requirements, most of which trace to a specific statute or regulation; treatment-plan review cadence mostly does not. That makes it easy to assume a number you heard once applies everywhere, when the number that actually controls is the one printed in your authorization letter or your specific payer contract.

This page addresses cadence only. The content the payer-proof treatment plan itself must contain, goals, measures, and diagnosis linkage, is a separate question answered on its own page. The practical response here is the same regardless of source: know where your specific deadline comes from, calendar it, and default to a shorter interval than any specific requirement demands when your own clinical judgment says the plan is going stale faster than the calendar assumes.

The common convention: review at a fixed interval, and always at renewal

A widely used practice convention reviews the treatment plan every 90 days, aligned with common payer authorization periods, regardless of whether a specific requirement mandates that exact number. Treat this as a sensible default absent a more specific deadline, not as a rule with independent legal force.

Ninety days also happens to be a natural checkpoint clinically, enough time for a goal to show real movement, short enough that a stalled or worsening picture gets caught before it goes unaddressed for a full course of treatment. Adopting it as a standing practice habit, independent of any specific payer's calendar, keeps every chart on a predictable rhythm.

Whatever interval you adopt as your default, always additionally review at the point any authorization actually expires. A plan that is current by your internal calendar but expired by the payer's calendar creates exactly the kind of gap a claims reviewer will flag.

What should trigger an earlier review, regardless of the calendar

A meaningful clinical change should move up the review date regardless of where you are in the normal interval, a new diagnosis, a shift in level of care, or a significant change in the client's presentation. For substance use care specifically, the level-of-care framework many payers reference is itself built around reassessing when the client's dimensions change, not on a fixed calendar alone 1Ref 1American Society of Addiction Medicine (2023).The ASAM Criteria.That level-of-care reassessment for substance use care is triggered by changes in the client's clinical dimensions, not solely by a fixed calendar..

A client who is stepping down from a higher level of care, or whose risk picture has shifted meaningfully since the plan was last reviewed, needs the plan updated at that moment, not held until the next scheduled date arrives. Waiting for the calendar when something clinically significant has already happened is the gap a later reviewer notices first.

Build the habit of asking, at any session where something changes meaningfully, whether the treatment plan on file still describes the actual course of care, and if it does not, treat that as its own trigger for an update rather than waiting.

Check the actual authorization period your payer gave you

The number that actually controls for insured clients is usually the specific authorization period stated in that client's approval, which you can typically find through the payer's own provider portal; behavioral health networks publish their own authorization and review workflows, and the interval one network states is not necessarily what another requires 2Ref 2Optum Behavioral Health (2026).Provider Express.Named as one behavioral health network's own published authorization and review workflow, an example rather than a universal payer standard..

Do not assume your last authorization period is this client's current one; authorization lengths can differ by diagnosis, level of care, or the specific plan the client is enrolled in, even within the same payer. Verify the actual date on file rather than working from memory of a typical interval.

Calendar the authorization expiration the moment you receive it, the same discipline you would apply to any other deadline with a financial consequence attached. A lapsed authorization found only when a claim is denied is a preventable gap.

Behavioral health can't be held to a shorter clock than medical care, without justification

Federal parity law requires that treatment limitations for behavioral health and substance use care be comparable to those applied to medical and surgical benefits, including how frequently a plan must be reauthorized, which is the framework for questioning a review interval that looks disproportionately short compared to what the same payer requires elsewhere 3Ref 3U.S. Department of Labor (2026).Mental Health and Substance Use Disorder Parity.That parity law requires behavioral health reauthorization frequency to be comparable to that required for medical and surgical care..

This does not set a specific number either; it sets a comparison. If a payer requires monthly plan reviews for behavioral health cases but a much longer interval for comparable medical conditions, that disparity is exactly what parity law is meant to reach, and payers are required to be able to produce the comparative analysis behind their own non-quantitative limitations on request.

Knowing this framework exists is useful even if you never file a complaint under it. It is part of why an unusually short review demand from a specific payer is worth questioning rather than simply accepted as standard practice.

The update that counts: what actually needs to change

A real update changes something on the document, a goal marked met and replaced, a revised target date, an adjusted level of care, and gets its own signature and date, the same authentication standard that applies to any other entry regardless of what triggered the update 4Ref 4Centers for Medicare & Medicaid Services (2023).Complying with Medicare Signature Requirements.That each treatment-plan update needs its own signature and date, the same authentication standard as any other entry.. Re-signing an unchanged plan on the renewal date is not the same as reviewing it.

A reviewer comparing two versions of the same plan across a renewal date is looking for evidence that something was actually reconsidered, not just that a date field changed. If nothing about the client's goals or circumstances has genuinely shifted, say so explicitly in the update rather than leaving the reviewer to guess whether the plan was actually reread.

Sign and date each update as its own entry, distinct from the original plan, so the chart shows a visible history of review rather than one document silently mutating over time.

Why payers watch this interval even when they don't dictate a specific number

Payers track outpatient follow-up patterns partly because national quality measure sets reward timely follow-up and ongoing management in behavioral health care, which gives payers a reason to care whether your plan reviews happen on a predictable rhythm even absent a rule naming a specific interval 5Ref 5National Committee for Quality Assurance (2026).HEDIS.That national quality measures rewarding timely follow-up give payers a reason to watch review-cadence consistency even without a specific mandated interval.. A practice with a visibly consistent review habit reads, in aggregate, as lower-risk than one with irregular gaps.

This is a reasonable, if indirect, incentive to keep your own review cadence consistent regardless of what any single payer explicitly requires: a predictable internal rhythm protects you across every payer relationship at once, rather than requiring you to track a different clock for each one.

Plan changes mid-treatment carry their own continuity-of-care dimension, distinct from routine review cadence, worth flagging separately when they come up. Treat your own default interval, whatever you settle on, as the floor you apply universally, and let each specific payer's actual authorization period be the exception you additionally track on top of it, not the other way around.

Common questions

No federal law sets that specific number. Ninety days is a common practice convention and a frequent payer authorization interval, but the actual controlling deadline is whatever your specific payer's authorization period or your accrediting standard requires; check the authorization letter or contract rather than assuming a universal rule.

A meaningful change in the client's clinical picture, a new diagnosis, a level-of-care change, a significant improvement or decline, should trigger a review regardless of where you are in the normal interval. Waiting for the scheduled date when something clinically significant has already changed leaves the plan out of step with the chart around it.

No. A real update changes something, a goal met and replaced, a new target date, a revised level of care, and should be signed and dated as its own entry. Re-signing an unchanged plan on the renewal date reads, to a reviewer, as a formality rather than a genuine clinical reassessment.

Parity law requires that treatment limitations for behavioral health be comparable to those for medical and surgical care, which is relevant if a review interval seems disproportionately short compared to what the same payer requires for other conditions. It doesn't eliminate the need to meet whatever the actual interval is, but it is the framework for questioning one that looks out of step.

In the authorization letter or the payer's own published provider policy, not a general industry assumption. Payers publish their own portals and policies stating expected reauthorization intervals, and your contract with that specific payer controls over any general convention you might otherwise assume applies.

Run your practice on Gale

The software is free. Gale earns one flat 3.5% all-in per paid transaction — only on transactions that actually pay. No subscription, no setup fee, no network cut.

Start or manage a practice →

References

1.American Society of Addiction Medicine (2023). The ASAM Criteria. American Society of Addiction Medicine. link ✓That level-of-care reassessment for substance use care is triggered by changes in the client's clinical dimensions, not solely by a fixed calendar.
2.Optum Behavioral Health (2026). Provider Express. Optum Behavioral Health. linkNamed as one behavioral health network's own published authorization and review workflow, an example rather than a universal payer standard.
3.U.S. Department of Labor (2026). Mental Health and Substance Use Disorder Parity. U.S. Department of Labor (EBSA). linkThat parity law requires behavioral health reauthorization frequency to be comparable to that required for medical and surgical care.
4.Centers for Medicare & Medicaid Services (2023). Complying with Medicare Signature Requirements. CMS Medicare Learning Network (MLN905364). link ✓That each treatment-plan update needs its own signature and date, the same authentication standard as any other entry.
5.National Committee for Quality Assurance (2026). HEDIS. National Committee for Quality Assurance (NCQA). link ✓That national quality measures rewarding timely follow-up give payers a reason to watch review-cadence consistency even without a specific mandated interval.

https://www.gale.care/for-providers/bhd-treatment-plan-review-cadence · 5 sources. Competitor details are cited to dated public sources and maintained as they change; figures are estimates, not commitments. Synthetic demonstration.

← Back to for providers